Fat‐Moon Suk

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen et al. · Liver International · 2016 · 221 citations

Pharmacy, Oncology, Pharmacotherapy +17

Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice

Hong-Jen Liang, Fat‐Moon Suk, Chung-Kwe Wang et al. · Chemico-Biological Interactions · 2009 · 120 citations

Medicine, Endocrinology, Pharmacology +11

Hypermodification and Immune Escape of an Internally Deleted Middle-Envelope (M) Protein of Frequent and Predominant Hepatitis B Virus Variants

Pei-Ching Tai, Fat‐Moon Suk, Wolfram H. Gerlich et al. · Virology · 2002 · 95 citations

Life Sciences, Infectious Diseases, Microbiology +16

ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner

Fat‐Moon Suk, Chi‐Ching Chang, Ren-Jye Lin et al. · Scientific Reports · 2018 · 91 citations · Full text

Life Sciences, Cell Biology, Oncology +15

Reduced Secretion of Virions and Hepatitis B Virus (HBV) Surface Antigen of a Naturally Occurring HBV Variant Correlates with the Accumulation of the Small S Envelope Protein in the Endoplasmic Reticulum and Golgi Apparatus

Pong Kian Chua, Robert Wang, Min-Hui Lin et al. · Journal of Virology · 2005 · 80 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16